Genelux Corp (GNLX) Stock Price, Quote & News

Company Profile

Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary modified strain of the vaccinia virus indicated for the treatment of ovarian cancer and non-small cell lung cancer, as well as for liquid or solid tumors, appendiceal, colorectal and gastric cancers, other gynecologic malignancies, and periton...

Industry: Biotechnology

Sector: Healthcare

Phone: 805 267 9889

Website: www.genelux.com

Address:

2625 Townsgate Road, Suite 230, Westlake Village, United States

CSkaugrud Jan. 8 at 5:02 PM

$GNLX

0 · Reply

DARKP00L Jan. 8 at 4:46 PM

$GNLX 11:46 on Jan. 08 2026 Genelux shares are trading lower. The company announced the pricing of a public offering of 6.67 million common shares at a price of $3.00 per share. #tradeideas

0 · Reply

DARKP00L Jan. 8 at 2:22 PM

$GNLX 09:15 on Jan. 08 2026 Genelux Prices ~$20M Public Offering Of 6.67M Shares At A Price Of $3/Share #tradeideas

0 · Reply

OpenOutcrier Jan. 8 at 2:08 PM

$GNLX (-10.6% pre) Genelux stock falls after announcing proposed public offering https://ooc.bz/l/89068

0 · Reply

cllebye Jan. 8 at 2:03 PM

$GNLX Buy and hold....

1 · Reply

sonofoj Jan. 8 at 7:39 AM

$GNLX when will be the next catalyst?

0 · Reply

AmaraNic Jan. 7 at 9:08 PM

$GNLX I’m so disappointed in this one.

0 · Reply

PaulLaurent Jan. 6 at 6:57 AM

🚀📈 Top Gainers 📈🚀AH $SKYQ $ALMS $GNLX $MEHA $LOCL

0 · Reply

topstockalerts Jan. 6 at 3:22 AM

After Hours Top Gainers PT2 $BSCR $VRME $ABOS $GNLX $UFG

0 · Reply

DiamondPlayz Jan. 5 at 10:17 PM

$GNLX Are you looking for the next potential reddit squeeze? Wallstreet-bets has recently squeezed a bunch of tickers for over 500%. Make sure to put ticker MGN on your watchlist. MGN has only 1 million free float and could be the next Reddit Squeeze. Seeing a lot of talks around this one. I bought a big position for a potential reddit squeeze !!,

0 · Reply

Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock

Jan 7, 2026, 4:01 PM EST - 21 hours ago

Genelux Corporation Announces Proposed Public Offering of Common Stock

Jan 2, 2026, 8:00 AM EST - 6 days ago

Genelux Corporation Announces Appointment of Jason Litten, M.D., as Chief Medical Officer

Nov 5, 2025, 4:20 PM EST - 2 months ago

Genelux Corporation Reports Third Quarter 2025 Financial Results and Provides General Business Updates

Aug 7, 2025, 4:20 PM EDT - 5 months ago

Genelux Corporation Reports Second Quarter 2025 Financial Results and Provides General Business Updates

Jul 7, 2025, 7:00 AM EDT - 6 months ago

Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development

May 6, 2025, 4:10 PM EDT - 8 months ago

Genelux Corporation Reports First Quarter 2025 Financial Results and Provides General Business Updates

Mar 28, 2025, 4:10 PM EDT - 10 months ago

Genelux Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Mar 25, 2025, 8:31 AM EDT - 10 months ago

Genelux Corporation Announces Pricing of $10.5 Million Underwritten Offering of Common Stock

Feb 3, 2025, 6:45 AM EST - 1 year ago

Genelux Corporation Announces New Chief Financial Officer

Dec 13, 2024, 7:01 AM EST - 1 year ago

Genelux Corporation to Participate in a Fireside Chat with H.C. Wainwright

Nov 6, 2024, 4:01 PM EST - 1 year ago

Genelux Corporation to Participate in Fireside Chat at the Guggenheim Inaugural Healthcare Innovation Conference

Oct 31, 2024, 10:59 AM EDT - 1 year ago

Genelux: 2nd Half Of 2025 PRROC Data Is Major Inflection Point

Oct 22, 2024, 4:01 PM EDT - 1 year ago

Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy with Olvi-Vec in Non-Small Cell Lung Cancer

Oct 9, 2024, 4:15 PM EDT - 1 year ago

Genelux Corporation to Participate in the 2024 Maxim Healthcare Virtual Summit

Sep 3, 2024, 4:01 PM EDT - 1 year ago

Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference

Aug 14, 2024, 4:05 PM EDT - 1 year ago

Genelux Corporation Reports Second Quarter 2024 Financial Results and Provides General Business Updates

Jul 30, 2024, 7:00 AM EDT - 1 year ago

Genelux Corporation to Participate in Fireside Chat at BTIG's Virtual Biotechnology Conference 2024

May 24, 2024, 8:00 AM EDT - 1 year ago

Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying Warrants

May 23, 2024, 4:01 PM EDT - 1 year ago

Genelux Corporation Announces Proposed Public Offering of Common Stock and Warrants

May 9, 2024, 4:25 PM EDT - 1 year ago

Genelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business Updates

Apr 1, 2024, 7:00 AM EDT - 1 year ago

Genelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

$Genelux Corporation Receives FDA Fast Track Designation for Olvi-Vec in Platinum Resistant/Refractory Ovarian Cancer$

Nov 27, 2023, 7:00 AM EST - 2 years ago

Genelux Corporation Receives FDA Fast Track Designation for Olvi-Vec in Platinum Resistant/Refractory Ovarian Cancer

Nov 14, 2023, 5:50 PM EST - 2 years ago

Genelux Corporation Reports Third Quarter 2023 Financial Results and Provides General Business Updates

Sep 14, 2023, 7:00 AM EDT - 2 years ago

Genelux Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aug 30, 2023, 1:56 PM EDT - 2 years ago

Genelux: Biotech To Watch With Oncolytic Virus Immunotherapy In Late-Stage Testing

Aug 14, 2023, 7:00 AM EDT - 2 years ago

Genelux Corporation Reports Second Quarter 2023 Financial Results and Provides General Business Updates

Aug 2, 2023, 4:00 PM EDT - 2 years ago

Genelux Corporation to Participate in Fireside Chat at BTIG's Virtual Biotechnology Conference 2023

Jul 20, 2023, 4:45 PM EDT - 2 years ago

Genelux Corporation Strengthens Senior Management and Clinical Team with Promotions and New Hires

Jul 11, 2023, 4:12 AM EDT - 2 years ago

Genelux: A Game Changer In Platinum-Resistant Ovarian Cancer

Jul 10, 2023, 7:00 AM EDT - 2 years ago

Genelux Corporation Announces Publication of Phase I Trial Results of Intrapleural Administration of Olvi-Vec in Patients with Malignant Pleural Effusion from Mesothelioma, Lung or Breast Cancers in Frontiers in Immunology

Jun 29, 2023, 7:00 AM EDT - 2 years ago

Genelux Corporation and TVAX Biomedical, Inc. announce the issuance of a United States patent covering the combination of an adoptive T cell therapy/oncolytic viral cancer treatment that is exclusively licensed to V2ACT Therapeutics™, LLC

Jun 22, 2023, 7:00 AM EDT - 2 years ago

Genelux Corporation Set to Join the Russell 3000® and Russell 2000® Indexes Effective June 26, 2023

Jun 12, 2023, 7:00 AM EDT - 2 years ago

Genelux Corporation Announces $18 Million Private Placement

$Genelux Corporation Announces Publication of Positive Topline Data from Phase 2 VIRO-15 Trial Evaluating Olvimulogene Nanivacirepvec (Olvi-Vec) in Platinum-Resistant or Refractory Ovarian Cancer in the Journal of the American Medical Association (JAMA) On$

May 25, 2023, 4:01 PM EDT - 2 years ago

Genelux Corporation Announces Publication of Positive Topline Data from Phase 2 VIRO-15 Trial Evaluating Olvimulogene Nanivacirepvec (Olvi-Vec) in Platinum-Resistant or Refractory Ovarian Cancer in the Journal of the American Medical Association (JAMA) On

May 15, 2023, 7:00 AM EDT - 2 years ago

Genelux Corporation Announces $33 Million Private Placement

Mar 26, 2023, 10:50 PM EDT - 3 years ago

Genelux: Recent IPO With Phase 3 Stage Oncolytic Virus Cancer Therapy

Mar 23, 2023, 7:00 AM EDT - 3 years ago

Genelux Corporation to Ring Nasdaq Opening Bell on March 29, 2023

Jan 26, 2023, 6:40 AM EST - 3 years ago

Genelux IPO prices at bottom of range

Jan 25, 2023, 9:00 PM EST - 3 years ago

Genelux Corporation Announces Pricing of Initial Public Offering

Sep 19, 2022, 1:49 PM EDT - 3 years ago

IPO Update: Genelux Finalizes $16 Million IPO Plan

Sep 19, 2022, 9:08 AM EDT - 3 years ago

Genelux sets IPO terms, as the biotech could be valued at up to $165 millino

CSkaugrud Jan. 8 at 5:02 PM

$GNLX

0 · Reply

DARKP00L Jan. 8 at 4:46 PM

$GNLX 11:46 on Jan. 08 2026 Genelux shares are trading lower. The company announced the pricing of a public offering of 6.67 million common shares at a price of $3.00 per share. #tradeideas

0 · Reply

DARKP00L Jan. 8 at 2:22 PM

$GNLX 09:15 on Jan. 08 2026 Genelux Prices ~$20M Public Offering Of 6.67M Shares At A Price Of $3/Share #tradeideas

0 · Reply

OpenOutcrier Jan. 8 at 2:08 PM

$GNLX (-10.6% pre) Genelux stock falls after announcing proposed public offering https://ooc.bz/l/89068

0 · Reply

cllebye Jan. 8 at 2:03 PM

$GNLX Buy and hold....

1 · Reply

sonofoj Jan. 8 at 7:39 AM

$GNLX when will be the next catalyst?

0 · Reply

AmaraNic Jan. 7 at 9:08 PM

$GNLX I’m so disappointed in this one.

0 · Reply

PaulLaurent Jan. 6 at 6:57 AM

🚀📈 Top Gainers 📈🚀AH $SKYQ $ALMS $GNLX $MEHA $LOCL

0 · Reply

topstockalerts Jan. 6 at 3:22 AM

After Hours Top Gainers PT2 $BSCR $VRME $ABOS $GNLX $UFG

0 · Reply

DiamondPlayz Jan. 5 at 10:17 PM

0 · Reply

thesaltier1 Jan. 5 at 9:21 PM

$GNLX I wouldn't touch this until we get a news release on how they plan on raising more capital, I was a long term holder in this but am waiting on the sidelines for now

1 · Reply

www_larval_com Jan. 5 at 8:58 PM

$GNLX -7%[-23%] $SNBR 5%[-7%] $KZIA 3%[15%] most notable movement into the final minutes of trading.

0 · Reply

justiceforb_85 Jan. 5 at 8:04 PM

$GNLX honestly, data did not look bad. More excited though about the P3 in PROC with an update possibly later this year.

0 · Reply

JohnTrack Jan. 5 at 4:16 PM

$GNLX watching if shorts cover...

0 · Reply

DARKP00L Jan. 5 at 1:22 PM

$GNLX 08:08 on Jan. 05 2026 Genelux Announces Interim Results From Two Ongoing Trials, Phase 1b/2 SCLC And Phase 2 VIRO-25, Evaluating Systemic Administration Of Olvi-Vec In Patients With Progressive SCLC And NSCLC #tradeideas

0 · Reply

JohnTrack Jan. 5 at 1:20 PM

$GNLX quick news... https://www.rapidticker.com/news/gnlx-sec-filing-0bd85f

0 · Reply

FrodoBag Jan. 3 at 12:14 AM

$GNLX any thoughts on CMO being replaced? Seems like the market is okay with it.

0 · Reply

JohnTrack Jan. 2 at 2:29 PM

$GNLX waiting for a cleaner read!

1 · Reply

JohnTrack Jan. 2 at 1:03 PM

$GNLX headline alert, grab link... https://www.rapidticker.com/news/gnlx-genelux-corporation-announces-appointment-of-ec67ce

0 · Reply

TheProtagonist Dec. 24 at 11:51 AM

$GNLX Market attention is shifting toward whether internal discipline offsets macro and competitive headwinds. Execution slippage remains the dominant downside risk.

1 · Reply

justiceforb_85 Dec. 23 at 5:23 AM

$GNLX next year this should be much higher.

0 · Reply

SuperGreenToday Dec. 19 at 7:42 PM

$GNLX Share Price: $4.16 Contract Selected: Jul 17, 2026 $10 Calls Buy Zone: $0.77 – $0.95 Target Zone: $1.26 – $1.54 Potential Upside: 56% ROI Time to Expiration: 209 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Market Cap	173.14M
Revenue (ttm)	10,000.00
Net Income (ttm)	-29.87M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-298,700.02%
Debt to Equity Ratio	0.00

Volume	1,035,594
Avg Vol	226,618
Day's Range	N/A - N/A
Shares Out	38.05M
Stochastic %K	4%
Beta	0.17
Analysts	Strong Sell
Price Target	$19.00